These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20838775)

  • 1. Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans.
    Sofuoglu M; Mooney M; Kosten T; Waters A; Hashimoto K
    Psychopharmacology (Berl); 2011 Jan; 213(1):61-8. PubMed ID: 20838775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atomoxetine attenuates dextroamphetamine effects in humans.
    Sofuoglu M; Poling J; Hill K; Kosten T
    Am J Drug Alcohol Abuse; 2009; 35(6):412-6. PubMed ID: 20014909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Riluzole and D-amphetamine interactions in humans.
    Sofuoglu M; Waters AJ; Mooney M; Kosten T
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):16-22. PubMed ID: 17714844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective responses predict d-amphetamine choice in healthy volunteers.
    Murray CH; Li J; Weafer J; de Wit H
    Pharmacol Biochem Behav; 2021 May; 204():173158. PubMed ID: 33675838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disulfiram enhances subjective effects of dextroamphetamine in humans.
    Sofuoglu M; Poling J; Waters A; Sewell A; Hill K; Kosten T
    Pharmacol Biochem Behav; 2008 Sep; 90(3):394-8. PubMed ID: 18474395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diltiazem, a calcium antagonist, partly attenuates the effects of dextroamphetamine in healthy volunteers.
    Fabian JE; Silverstone PH
    Int Clin Psychopharmacol; 1997 Mar; 12(2):113-20. PubMed ID: 9219047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contextual conditioning enhances the psychostimulant and incentive properties of d-amphetamine in humans.
    Childs E; de Wit H
    Addict Biol; 2013 Nov; 18(6):985-92. PubMed ID: 22129527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphetamine sensitization alters reward processing in the human striatum and amygdala.
    O'Daly OG; Joyce D; Tracy DK; Azim A; Stephan KE; Murray RM; Shergill SS
    PLoS One; 2014; 9(4):e93955. PubMed ID: 24717936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Route of administration affects the ability of naltrexone to reduce amphetamine-potentiated brain stimulation reward in rats.
    Todtenkopf MS; O'Neill KS; Kriksciukaite K; Turncliff RZ; Dean RL; Ostrovsky-Day I; Deaver DR
    Addict Biol; 2009 Sep; 14(4):408-18. PubMed ID: 19489752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence.
    Jayaram-Lindström N; Konstenius M; Eksborg S; Beck O; Hammarberg A; Franck J
    Neuropsychopharmacology; 2008 Jul; 33(8):1856-63. PubMed ID: 17957221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate attenuates dextroamphetamine-induced subjective changes more than lithium.
    Willson MC; Bell EC; Dave S; Asghar SJ; McGrath BM; Silverstone PH
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):633-9. PubMed ID: 15949922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hydrocortisone administration does not affect subjective responses to d-amphetamine in humans.
    Wachtel SR; Charnot A; de Wit H
    Psychopharmacology (Berl); 2001 Jan; 153(3):380-8. PubMed ID: 11271411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rewarding effects of physical activity predict sensitivity to the acute subjective effects of d-amphetamine in healthy volunteers.
    Pester MS; Kirkpatrick MG; Geary BA; Leventhal AM
    J Psychopharmacol; 2018 Mar; 32(3):302-308. PubMed ID: 29338486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of progesterone pretreatment on the response to oral d-amphetamine in Women.
    Reed SC; Levin FR; Evans SM
    Horm Behav; 2010 Aug; 58(3):533-43. PubMed ID: 20399212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men.
    Boileau I; Dagher A; Leyton M; Gunn RN; Baker GB; Diksic M; Benkelfat C
    Arch Gen Psychiatry; 2006 Dec; 63(12):1386-95. PubMed ID: 17146013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium and valproate attenuate dextroamphetamine-induced changes in brain activation.
    Bell EC; Willson MC; Wilman AH; Dave S; Asghar SJ; Silverstone PH
    Hum Psychopharmacol; 2005 Mar; 20(2):87-96. PubMed ID: 15651051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human response to repeated low-dose d-amphetamine: evidence for behavioral enhancement and tolerance.
    Strakowski SM; Sax KW; Rosenberg HL; DelBello MP; Adler CM
    Neuropsychopharmacology; 2001 Oct; 25(4):548-54. PubMed ID: 11557168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing brain reward system function in major depressive disorder: altered response to dextroamphetamine.
    Tremblay LK; Naranjo CA; Cardenas L; Herrmann N; Busto UE
    Arch Gen Psychiatry; 2002 May; 59(5):409-16. PubMed ID: 11982444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress-induced changes in mood and cortisol release predict mood effects of amphetamine.
    Hamidovic A; Childs E; Conrad M; King A; de Wit H
    Drug Alcohol Depend; 2010 Jun; 109(1-3):175-80. PubMed ID: 20176450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mood-elevating effects of d-amphetamine and incentive salience: the effect of acute dopamine precursor depletion.
    Leyton M; aan het Rot M; Booij L; Baker GB; Young SN; Benkelfat C
    J Psychiatry Neurosci; 2007 Mar; 32(2):129-36. PubMed ID: 17353942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.